Johnson & Johnson unit Janssen hit with $8bn drug damages verdict
Risperdal antipsychotic medicine is blamed for causing adolescent boys to grow female-sized breasts
09 October 2019 - 16:22
Delaware/New York — Johnson & Johnson’s Janssen unit was hit with an $8bn punitive-damages verdict — the largest jury award in the US in 2019 — over its alleged mishandling of an antipsychotic drug blamed for causing adolescent boys to grow female-sized breasts.
A state court jury in Philadelphia concluded on Tuesday that Janssen’s wrongful marketing of its Risperdal drug to teens warrants the punishment award in the first Pennsylvania case in which such damages could be awarded under an appellate ruling...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.